Comparison of qualitative and quantitative approach to prostate MR spectroscopy in peripheral zone cancer detection

European Journal of Radiology

Volumn 81, Issue 3, 2012, Pages 411-416

  Klijn, Stijn ^a,b   De Visschere, Pieter J ^a   De Meerleer, Gert O ^a   Villeirs, Geert M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diagnostic techniques and procedures; Image interpretation; Magnetic resonance imaging; Magnetic resonance spectroscopy; Prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; COMPUTER PROGRAM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PATTERN RECOGNITION, AUTOMATED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SOFTWARE;

EID: 84856972335     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.12.017     Document Type: Article

References (30)

1. L.C. Costello, and R.B. Franklin The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy Oncology 59 2000 269 282
2. E. Ackerstaff, B.R. Pflug, J.B. Nelson, and Z.M. Bhujwalla Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells Cancer Res 61 2001 3599 3603
3. K. Glunde, E. Ackerstaff, N. Mori, M.A. Jacobs, and Z.M. Bhujwalla Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions Mol Pharm 3 2006 496 506
4. J. Scheidler, H. Hricak, and D.B. Vigneron Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study Radiology 213 1999 473 480
5. G.M. Villeirs, G.O. De Meerleer, P.J. De Visschere, V.H. Fonteyne, A.C. Verbaeys, and W. Oosterlinck Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients Eur J Radiol 2009 10.1016/j.ejrad.2009.08.007
6. K.L. Zakian, K. Sircar, and H. Hricak Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy Radiology 234 2005 804 814
7. M. Umbehr, L.M. Bachmann, and U. Held Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis Eur Urol 55 2009 575 591
8. E. Casciani, E. Polettini, and L. Bertini Contribution of the MR spectroscopic imaging in the diagnosis of prostate cancer in the peripheral zone Abdom Imaging 32 2007 796 802
9. S. Cirillo, M. Petracchini, and P. Della Monica Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours Clin Radiol 63 2008 871 879
10. N.G. Costouros, F.V. Coakley, and A.C. Westphalen Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging AJR Am J Roentgenol 188 2007 812 816
11. 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study Radiology 221 2001 380 390
12. A. Prando, J. Kurhanewicz, A.P. Borges, E.M. Oliveira Jr., and E. Figueiredo Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience Radiology 236 2005 903 910
13. A. Shukla-Dave, H. Hricak, and M.W. Kattan The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis BJU Int 99 2007 786 793
14. A. Shukla-Dave, H. Hricak, and C. Moskowitz Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines Radiology 245 2007 499 506
15. E. Squillaci, G. Manenti, and S. Mancino MR spectroscopy of prostate cancer. Initial clinical experience J Exp Clin Cancer Res 24 2005 523 530
16. C. Testa, R. Schiavina, and R. Lodi Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT Radiology 244 2007 797 806
17. A.E. Wefer, H. Hricak, and D.B. Vigneron Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology J Urol 164 2000 400 404
18. 1H-magnetic resonance spectroscopy of the prostate in clinical practice: technique and results in patients with elevated prostate-specific antigen and negative or no previous prostate biopsies Eur Radiol 15 2005 645 652
19. G.M. Villeirs, W. Oosterlinck, E. Vanherreweghe, and G.O. De Meerleer A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer Eur J Radiol 73 2010 352 356
20. J.S. Yuen, C.H. Thng, and P.H. Tan Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy J Urol 171 2004 1482 1486
21. T.W. Scheenen, D.W. Klomp, S.A. Roll, J.J. Futterer, J.O. Barentsz, and A. Heerschap Fast acquisition-weighted three-dimensional proton MR spectroscopic imaging of the human prostate Magn Reson Med 52 2004 80 88
22. 3) spatial resolution Radiology 198 1996 795 805
23. J.A. Jung, F.V. Coakley, and D.B. Vigneron Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system Radiology 233 2004 701 708
24. M.J. Lynch, J. Masters, and J.P. Pryor Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions J Pharm Biomed Anal 12 1994 5 19
25. L. Klotz Active surveillance with selective delayed intervention using PSA doubling time for good risk prostate cancer Eur Urol 47 2005 16 21
26. J.A. Hanley, and B.J. McNeil A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 148 1983 839 843
27. T. Scheenen, E. Weiland, and S. Roell Intermediate results of IMAPS: an international multi-centre assessment of prostate MR spectroscopy Proc Intl Soc Mag Reson Med 14 2006 115
28. U.G. Mueller-Lisse, M.G. Swanson, and D.B. Vigneron Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging Magn Reson Med 46 2001 49 57
29. T. Scheenen, J. Fütterer, and E. Weiland Discriminating cancer from non-cancer tissue in the prostate by three-dimensional proton magnetic resonance spectroscopic imaging: a prospective multi-center validation study Invest Radiol 2010 10.1097/RLI.0b013e3181f54081
30. 1H magnetic resonance spectroscopic imaging Magn Reson Med 43 2000 17 22